Primary androgen deprivation (PAD) followed by active surveillance for newly diagnosed prostate cancer (PC)

被引:0
|
作者
Scholz, Mark Creamer
Groom, Meg
Kaddis, Andrew
Lam, Richard Y.
Jennrich, Robert
机构
[1] Prostate Oncol Specialists, Marina Del Rey, CA USA
[2] Univ Calif Los Angeles, Los Angeles, CA USA
关键词
D O I
10.1200/jco.2012.30.5_suppl.244
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
244
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Androgen deprivation and cognition in prostate cancer
    Salminen, E
    Portin, R
    Korpela, J
    Backman, H
    Parvinen, LM
    Helenius, H
    Nurmi, M
    BRITISH JOURNAL OF CANCER, 2003, 89 (06) : 971 - 976
  • [42] Androgen deprivation treatment in prostate cancer
    Thomas, Benjamin C.
    Neal, David E.
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [43] Early androgen deprivation for prostate cancer?
    Eisenberger, MA
    Walsh, PC
    NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (24): : 1837 - 1838
  • [44] Androgen deprivation therapy for prostate cancer
    Singer, Eric A.
    Golijanin, Dragan J.
    Miyamoto, Hiroshi
    Messing, Edward M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (02) : 211 - 228
  • [45] Re: Intermittent Androgen Deprivation (IAD) in Prostate Cancer (PC): Are We Ready To Quit?
    Lange, Paul H.
    EUROPEAN UROLOGY, 2016, 70 (03) : 542 - 543
  • [46] IMPACT OF TRANSIENT ANDROGEN DEPRIVATION THERAPY (ADT) WITH LEUPRORELIN LP 11.25 MG ON THE HISTOLOGICAL PROGRESSION OF INDOLENT PROSTATE CANCER (PC)-RESULTS OF A PHASE III TRIAL VERSUS ACTIVE SURVEILLANCE (AS) IMPACT OF TRANSIENT ANDROGEN DEPRIVATION THERAPY (ADT) WITH LEUPRORELIN LP 11.25 MG ON THE HISTOLOGICAL PROGRESSION OF INDOLENT PROSTATE CANCER (PC)-RESULTS OF A PHASE III TRIAL VERSUS ACTIVE SURVEILLANCE (AS)
    Cussenot, Olivier
    Penna, Raphaele Renard
    Comperat, Eva
    Azzouzi, Abdel-Rahmene
    Costa, Pierre
    Larre, Stephane
    Ruffion, Alain
    Fasla, Ludmila
    Delavierre, Dominque
    Rebillard, Xavier
    Pfister, Christian
    Fendler, Jean-Philippe
    Vesga, Jorgea Villamizar
    Staerman, Frederic
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1076 - E1077
  • [47] ALADDIN: Evaluation of darolutamide addition to androgen deprivation therapy and radiation therapy in newly diagnosed prostate cancer with pelvic lymph nodes metastases
    Oudard, Stephane
    Combe, Pierre
    Boisserie, Thomas
    Hasbini, Ali
    Leroy, Thomas
    Supiot, Stephane
    Schick, Ulrike
    Mesgouez-Nebout, Nathalie
    Pasquier, David
    Fumagalli, Ingrid
    Khalifa, Jonathan
    Iriart, Carole
    Adrien, Laville
    Sargos, Paul
    Ruffier, Amandine
    Riet, Francois-Georges
    Martin, Etienne
    Cartier, Lysian
    Graff-Cailleaud, Pierre
    Bibault, Jean-Emmanuel
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [48] Low Serum Testosterone in Men with Newly Diagnosed Androgen-Deprivation Therapy-Naive Prostate Cancer and Its Relationship to Cardiovascular Risk Factors: A RADICAL-PC Substudy
    Pinthus, Jehonathan H.
    Duivenvoorden, Wilhelmina C. M.
    Klotz, Laurence
    Mukherjee, Som D.
    Siemens, D. Robert
    Niazi, Tamim
    Fradet, Vincent
    Foster, William
    Duceppe, Emmanuelle
    Taussky, Daniel
    Hamilton, Robert
    Lavallee, Luke
    Brown, Ian
    Chin, Joseph
    Gopaul, Darin
    Wassef, Anthony
    Kassouf, Wassim
    Davis, Margot
    Violette, Philippe D.
    Agapay, Steve
    Balasubramanian, Kumar
    Mian, Rajibul
    Rangarajan, Sumathy
    Sener, Alp
    Shayegan, Bobby
    Devereaux, P. J.
    Leong, Darryl P.
    JOURNAL OF UROLOGY, 2022, 207 (05): : 1020 - 1028
  • [49] Development and External Validation of the STRATified CANcer Surveillance (STRATCANS) Multivariable Model for Predicting Progression in Men with Newly Diagnosed Prostate Cancer Starting Active Surveillance
    Light, Alexander
    Lophatananon, Artitaya
    Keates, Alexandra
    Thankappannair, Vineetha
    Barrett, Tristan
    Dominguez-Escrig, Jose
    Rubio-Briones, Jose
    Benheddi, Toufik
    Olivier, Jonathan
    Villers, Arnauld
    Babureddy, Kirthana
    Abdelmoteleb, Haitham
    Gnanapragasam, Vincent J.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (01)
  • [50] Risk of the "androgen deprivation syndrome" in men receiving androgen deprivation for prostate cancer
    Shahinian, VB
    Kuo, YF
    Freeman, JL
    Goodwin, JS
    ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (04) : 465 - 471